Antimesothelin Immunotoxin Shows Potential for Malignant Pleural Mesothelioma

Mesothelin-targeted immunotoxin therapy is well tolerated by patients undergoing pemetrexed-cisplatin chemotherapy for malignant pleural mesothelioma...

ESMO members: your membership includes full access to OncologyPRO Daily News, created exclusively for you by medwireNews. Sign in now to access this page.